A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction
Yuan Zhang, Maros Elsik, Amanda J Edgley, Alison J Cox, Andrew R Kompa, Bing Wang, Christina Yan Ru Tan, Fay L Khong, David I Stapleton, Steven Zammit, Spencer J Williams, Richard E Gilbert, Henry Krum, Darren J Kelly
International Journal of Cardiology | ELSEVIER IRELAND LTD | Published : 2013
Awarded by NHMRC Program Grants
Darren J Kelly is a National Health and Medical Research Council of Australia (NHMRC) Senior Fellow. Richard E. Gilbert is the Canada Research Chair in Diabetes Complications. This work was supported in part by the NHMRC Program Grants (#546272 and #334008), Fibrotech Therapeutics Pty Ltd and the Canada Research Chair Program. The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology.